The term “cachexia” is derived from the Greek words kakos (bad) and hexis (habit).
Cachexia is a malnutrition associated with chronic diseases such as cancer, chronic heart …

Sarcopenia is a progressive systemic skeletal muscle disorder characterized by a
pathological decline in muscle strength, quantity, and quality, which frequently affects the …

In cancer cachexia trials, measures of physical function are commonly used as endpoints.
For drug trials to obtain regulatory approval, efficacy in physical function endpoints may be …

Low in dietary ω3 polyunsaturated fatty acid (PUFA) consumption has been associated with
increased incidence of cancers. Many basic and clinical studies have been conducted over …

Lung cancer is the most common cause of cancer death and is associated with malnutrition
and sarcopenia. The detection of sarcopenia and conduction of simple body composition …

Cancer-associated cachexia represents a multifactorial syndrome mainly characterized by
muscle mass loss, which causes both a decrease in quality of life and anti-cancer therapy …

Background & aims The high prevalence of malnutrition in non-small cell lung cancer
(NSCLC) patients has numerous negative consequences on patients' outcome when …

The supportive care of people with cancer cachexia is a rapidly evolving field. In the past
decade, multimodal treatments have been developed and new multidisciplinary cachexia …

Cachexia is a syndrome characterized by involuntary weight loss and wasting of skeletal
muscle mass. It is associated with worse overall survival and quality of life. The cancer …

Cancer cachexia (CC) is a debilitating multifactorial syndrome, involving progressive
deterioration and functional impairment of skeletal muscles. It affects about 80% of patients …